Evidence map›Paper›PMID 37325846›Full record

ArticleNanoscale2023

Redox double-switch cancer theranostics through Pt(IV) functionalised manganese dioxide nanostructures.

Beatriz Brito, Maria Rosaria Ruggiero, Thomas W Price, Milene da Costa Silva, Núria Genicio, Annah J Wilson, Olga Tyurina, Veronika Rosecker, Thomas R Eykyn, Manuel Bañobre-López and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Nanoscale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Beatriz BritoDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.ORCID http://orcid.org/0000-0002-1955-6215
Maria Rosaria RuggieroDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.
Thomas W PriceDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.
Milene da Costa SilvaAdvanced Magnetic Theranostic Nanostructures Lab, International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, 4715-330 Braga, Portugal. juan.gallo@inl.int.ORCID http://orcid.org/0000-0001-6951-2504
Núria GenicioAdvanced Magnetic Theranostic Nanostructures Lab, International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, 4715-330 Braga, Portugal. juan.gallo@inl.int.
Annah J WilsonDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.
Olga TyurinaDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.
Veronika RoseckerDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.ORCID http://orcid.org/0000-0003-0772-7272
Thomas R EykynDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.ORCID http://orcid.org/0000-0003-1768-3808
Manuel Bañobre-LópezAdvanced Magnetic Theranostic Nanostructures Lab, International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, 4715-330 Braga, Portugal. juan.gallo@inl.int.ORCID http://orcid.org/0000-0003-4319-2631
Graeme J StasiukDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, Strand, WC2R 2LS London, UK. graeme.stasiuk@kcl.ac.uk.ORCID http://orcid.org/0000-0002-0076-2246
Juan GalloAdvanced Magnetic Theranostic Nanostructures Lab, International Iberian Nanotechnology Laboratory, Av. Mestre José Veiga, 4715-330 Braga, Portugal. juan.gallo@inl.int.ORCID http://orcid.org/0000-0002-2028-3234
King's College London · GBInternational Iberian Nanotechnology Laboratory · PT

Funding

Medical Research Council MC_PC_19041Medical Research Council MR/T002573/1Wellcome Trust
6 · The paper itself

Abstract

Manganese dioxide (MnO

Indexed as

NanoparticlesNanostructuresNeoplasmsProdrugsAnimalsCisplatinManganese CompoundsMiceOxidation-ReductionOxidesPrecision MedicineCisplatinManganese Compoundsmanganese dioxideOxidesProdrugs

Identifiers

PMID37325846
PMCPMC10311465
OpenAlexW4380628699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.